Misty Barebo
Family · Huntington, WVNPI 1174802821
Payments from drug & device makers
What this record shows
AbbVie accounts for 68.8% of it on its own, with 53 other manufacturers making up the rest. Reporting peaked in 2021 at $10,629 and has fallen 80.8% since, to $2,040 in 2025. Among family clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 607 payments — averaging $41.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$17K
- Biogen$673
- Novo Nordisk$668
- AstraZeneca$581
- Teva Pharmaceuticals USA, Inc.$448
- E.r. Squibb & Sons, L.L.C.$433
- plus $5K from 48 others
What the payments were for
- Speaking & faculty fees$14,60558%
- Food & beverage$10,51442%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,119 in reported general payments places this provider in the 95th percentile of 1,507 family providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Emgality PenGalcanezumab-Gnlm | 28 | $20,950 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 16 | $12,048 |
| Aimovig AutoinjectorErenumab-Aooe | 11 | $7,931 |
| Levetiracetam | 101 | $2,425 |
| Lacosamide | 22 | $1,504 |
| Topiramate | 97 | $833 |
| Amitriptyline Hcl | 50 | $626 |
| Memantine Hcl | 38 | $610 |
| Donepezil Hcl | 71 | $504 |
| ClopidogrelClopidogrel Bisulfate | 36 | $401 |
| Primidone | 19 | $192 |
| Gabapentin | 30 | $160 |
| Nortriptyline Hcl | 13 | $113 |
| RizatriptanRizatriptan Benzoate | 12 | $89 |
| Clonazepam | 18 | $45 |
Paid to pharmacies, not to this prescriber.
Other family in Huntington
- Jennifer FieldsHuntington$32K
- Anne GharibHuntington$23K
- Mary VaughnHuntington$10K
- Maegen BrennanHuntington$10K
- Betty WaddellHuntington$10K
- Lana TrentHuntington$9K
- Ashley ComerCharleston$213K
- Dana CruseParkersburg$109K
- Sarah KnightCharleston$99K
- Star RoeBarboursville$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.